EPI Health a Novan Company Enters into Exclusive License Agreement with Sato Pharmaceutical Co Ltd for RHOFADE
By, Admin1 min read
Share
Novan Inc today announced that EPI Health, LLC, a fully consolidated subsidiary of Novan, has entered into an exclusive license agreement with Sato Pharmaceutical Co., Ltd. (
Found this useful? Share it with your team.
Newsletter
Stay ahead with Clival insights
Subscribe to get the latest updates, data releases and industry information — straight to your inbox.
